Pharmaceutical Contract Sales Outsourcing Market Size Worth USD 14.5 Bn by 2030

SHARE THIS ARTICLE

The global pharmaceutical contract sales outsourcing market size was valued at USD 7.1 billion in 2020 and is expected to reach USD 14.5 billion by 2030, growing at a CAGR of 7.2% from 2021 to 2030.

Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38524

Pharmaceutical Contract Sales Outsourcing Market Size 2021 to 2030

Key Players

The report provides profiles of leading players operating in the global pharmaceutical contract sales outsourcing (CSO) market. These include Ashfield (UDG Healthcare plc), inVentiv Health, Inc. (Syneos Health), IQVIA, Granard Pharmaceutical Sales & Marketing, Vanguard Pharma, Inc., GTS Solution, EVERSANA, MaBiCo, QFR Solutions, Pharmaforce Ireland Ltd., Sales Focus, Inc., Amplity Health, and PharmaLex GmbH.

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market: Segmentation

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Service

  • Personal Promotion
      • Promotional Sales Team
        • Dedicated Sales Team
        • Syndicated Sales Team
      • Key Account Management
      • Vacancy Management
  • Non-personal Promotion
      • Tele-detailing
      • Interactive E-detailing
      • Customer Service
      • Medical Science Liaisons
      • Patient Engagement Services
      • Others (telesampling)
  • Others (Field Management/Reporting and Sales Training)

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Therapeutic Area

    • Cardiovascular Disorders
    • Oncology
    • Metabolic Disorders
    • Neurology
    • Orthopedic Diseases
    • Infectious Diseases
    • Others

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Region

  • North America
      • U.S.
      • Canada
  • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
  • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia & New Zealand
      • Rest of Asia Pacific
  • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

Table of Contents

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Pharmaceutical Contract Sales Outsourcing Market, By Service

7.1.  Pharmaceutical Contract Sales Outsourcing Market, by Service, 2021-2030

7.1.1.     Personal Promotion

7.1.1.1.          Market Revenue and Forecast (2016-2030)

7.1.2.     Non-personal Promotion

7.1.2.1.          Market Revenue and Forecast (2016-2030)

7.1.3.     Others (Field Management/Reporting and Sales Training)

7.1.3.1.          Market Revenue and Forecast (2016-2030)

Chapter 8.    Global Pharmaceutical Contract Sales Outsourcing Market, By Therapeutic Area

8.1.  Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021-2030

8.1.1.     Cardiovascular Disorders

8.1.1.1.          Market Revenue and Forecast (2016-2030)

8.1.2.     Oncology

8.1.2.1.          Market Revenue and Forecast (2016-2030)

8.1.3.     Metabolic Disorders

8.1.3.1.          Market Revenue and Forecast (2016-2030)

8.1.4.     Neurology

8.1.5.     Market Revenue and Forecast (2016-2030)

8.1.6.     Orthopedic Diseases

8.1.6.1.          Market Revenue and Forecast (2016-2030)

8.1.7.     Infectious Diseases

8.1.7.1.          Market Revenue and Forecast (2016-2030)

8.1.8.     Others

8.1.8.1.          Market Revenue and Forecast (2016-2030)

Chapter 9.    Global Pharmaceutical Contract Sales Outsourcing Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.     Market Revenue and Forecast, by Service (2016-2030)

9.1.2.     Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.1.3.     U.S.

9.1.3.1.          Market Revenue and Forecast, by Service (2016-2030)

9.1.3.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.1.4.     Rest of North America

9.1.4.1.          Market Revenue and Forecast, by Service (2016-2030)

9.1.4.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.2.  Europe

9.2.1.     Market Revenue and Forecast, by Service (2016-2030)

9.2.2.     Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.2.3.     UK

9.2.3.1.          Market Revenue and Forecast, by Service (2016-2030)

9.2.3.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.2.4.     Germany

9.2.4.1.          Market Revenue and Forecast, by Service (2016-2030)

9.2.4.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.2.5.     France

9.2.5.1.          Market Revenue and Forecast, by Service (2016-2030)

9.2.5.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.2.6.     Rest of Europe

9.2.6.1.          Market Revenue and Forecast, by Service (2016-2030)

9.2.6.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.3.  APAC

9.3.1.     Market Revenue and Forecast, by Service (2016-2030)

9.3.2.     Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.3.3.     India

9.3.3.1.          Market Revenue and Forecast, by Service (2016-2030)

9.3.3.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.3.4.     China

9.3.4.1.          Market Revenue and Forecast, by Service (2016-2030)

9.3.4.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.3.5.     Japan

9.3.5.1.          Market Revenue and Forecast, by Service (2016-2030)

9.3.5.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.3.6.     Rest of APAC

9.3.6.1.          Market Revenue and Forecast, by Service (2016-2030)

9.3.6.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.4.  MEA

9.4.1.     Market Revenue and Forecast, by Service (2016-2030)

9.4.2.     Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.4.3.     GCC

9.4.3.1.          Market Revenue and Forecast, by Service (2016-2030)

9.4.3.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.4.4.     North Africa

9.4.4.1.          Market Revenue and Forecast, by Service (2016-2030)

9.4.4.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.4.5.     South Africa

9.4.5.1.          Market Revenue and Forecast, by Service (2016-2030)

9.4.5.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.4.6.     Rest of MEA

9.4.6.1.          Market Revenue and Forecast, by Service (2016-2030)

9.4.6.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.5.  Latin America

9.5.1.     Market Revenue and Forecast, by Service (2016-2030)

9.5.2.     Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.5.3.     Brazil

9.5.3.1.          Market Revenue and Forecast, by Service (2016-2030)

9.5.3.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.5.4.     Rest of LATAM

9.5.4.1.          Market Revenue and Forecast, by Service (2016-2030)

9.5.4.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

Chapter 10.   Company Profiles

10.1.                 Ashfield (UDG Healthcare plc)

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.                 inVentiv Health

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.                 Inc. (Syneos Health)

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.                 IQVIA

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.                 Granard Pharmaceutical Sales & Marketing

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.                 Vanguard Pharma Inc.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.                 GTS Solution

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.                 EVERSANA

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.                 MaBiCo

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.              MaBiCo

10.10.1.                   Company Overview

10.10.2.                   Product Offerings

10.10.3.                   Financial Performance

10.10.4.                   Recent Initiatives

Chapter 11.   Research Methodology

11.1.                 Primary Research

11.2.                 Secondary Research

11.3.                 Assumptions

Chapter 12.   Appendix

12.1.                 About Us

12.2.                 Glossary of Terms

Research Methodology

The research methodology adopted by analysts for compiling the global pharmaceutical contract sales outsourcing market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global pharmaceutical contract sales outsourcing market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2021) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38524 or call: +1 9197 992 333

Daksh

Daksh is an SEO Analyst having 3 years of experienced. we can quickly understand and support initiatives that will contribute to the goals and success of client campaigns. and also Perform keyword research in coordination with client business objectives to optimize existing content and uncover new opportunities.

View all posts by Daksh →

Leave a Reply

Your email address will not be published. Required fields are marked *